Publication: An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.
Loading...
Identifiers
Publication date
2021-04-16
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Publishing Group
Abstract
The molecular landscape in non-muscle-invasive bladder cancer (NMIBC) is characterized by large biological heterogeneity with variable clinical outcomes. Here, we perform an integrative multi-omics analysis of patients diagnosed with NMIBC (n = 834). Transcriptomic analysis identifies four classes (1, 2a, 2b and 3) reflecting tumor biology and disease aggressiveness. Both transcriptome-based subtyping and the level of chromosomal instability provide independent prognostic value beyond established prognostic clinicopathological parameters. High chromosomal instability, p53-pathway disruption and APOBEC-related mutations are significantly associated with transcriptomic class 2a and poor outcome. RNA-derived immune cell infiltration is associated with chromosomally unstable tumors and enriched in class 2b. Spatial proteomics analysis confirms the higher infiltration of class 2b tumors and demonstrates an association between higher immune cell infiltration and lower recurrence rates. Finally, the independent prognostic value of the transcriptomic classes is documented in 1228 validation samples using a single sample classification tool. The classifier provides a framework for biomarker discovery and for optimizing treatment and surveillance in next-generation clinical trials.
Description
Keywords
MeSH Terms
Aged BCG Vaccine Biomarkers, Tumor Carcinoma, Transitional Cell Chromosomal Instability Cystectomy Denmark Female Follow-Up Studies Gene Expression Regulation, Neoplastic Genomics Humans Kaplan-Meier Estimate Male Mutation Neoplasm Recurrence, Local Prognosis Progression-Free Survival RNA-Seq Urinary Bladder Urinary Bladder Neoplasms
DeCS Terms
Bibliographic citation
Nat Commun . 2021 ;12(1):2301